Nifty MidSmall Healthcare

Nifty MidSmall Healthcare logo

Nifty MidSmall Healthcare tracks the performance of the mid cap and small cap stocks within the healthcare sector. The index includes upto 30 stocks selected from the parent Nifty MidSmallcap 400 index based on the stock’s six-month average free-float market capitalization. The weight of each stock in the index is based on stock’s free float market capitalization.

Nifty MidSmall Healthcare Index can be used for a variety of purposes such as benchmarking fund portfolios, launching of index funds, ETFs and structured products.

          

Nifty MidSmall Healthcare Constituents

Price22,543.25 -295.10 (-1.29%)52 Week High24,744.25
ISININE358A0101452 Week Low17,481.80
IndustryPharmaceuticals: MajorVolume9,333
SectorHealth TechnologyP/E Ratio TTM46.33
Market Cap485.4 B1 Year Beta-0.12
Technical Rating of
Abbott India Limited (ABBOTINDIA) is a subsidiary of Abbott Laboratories, a global healthcare company headquartered in Abbott Park, Illinois, United States. Abbott India is headquartered in Gurgaon, Haryana, and has a presence in over 50 cities across India. ABBOTINDIA is a leading provider of healthcare products and services in India. The company’s products and services more about Abbott India Limited (ABBOTINDIA)

Price1,705.90 -16.80 (-0.98%)52 Week High1,904.45
ISININE031B0104952 Week Low1,111.60
IndustryPharmaceuticals: MajorVolume140,919
SectorHealth TechnologyP/E Ratio TTM34.84
Market Cap216.6 B1 Year Beta-0.30
Technical Rating of
Ajanta Pharma Limited (AJANTPHARM) is an Indian pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1973. The company’s initial focus was on the manufacturing of generic formulations. Ajanta Pharma has since expanded its operations to include a wide range of pharmaceutical products, including branded formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. more about Ajanta Pharma Limited (AJANTPHARM)

Price752.20 -12.65 (-1.65%)52 Week High826.75
ISININE901L0101852 Week Low462.30
IndustryPharmaceuticals: MajorVolume160.9 T
SectorHealth TechnologyP/E Ratio TTM27.98
Market Cap150.5 B1 Year Beta0.62
Technical Rating of
Alembic Pharmaceuticals Limited (APLLTD) is an Indian pharmaceutical company headquartered in Vadodara, Gujarat, India. It was incorporated in 1982. The company is a subsidiary of Alembic Limited, which is one of the leading pharmaceutical companies in India. Alembic Pharmaceuticals is focused on the development and manufacture of branded generics and specialty pharmaceuticals. Alembic Pharmaceuticals has more about Alembic Pharmaceuticals Limited (APLLTD)

Price3,550.65 -101.20 (-2.77%)52 Week High4,243.00
ISININE540L0101452 Week Low2,940.05
IndustryPharmaceuticals: MajorVolume267.5 T
SectorHealth TechnologyP/E Ratio TTM37.13
Market Cap436.6 B1 Year Beta0.41
Technical Rating of
Alkem Laboratories Limited (ALKEM) is an Indian pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1973. The company’s initial focus was on the manufacturing of bulk drugs. Alkem has since expanded its operations to include a wide range of pharmaceutical products, including formulations, active pharmaceutical ingredients (APIs), and contract manufacturing services. Alkem is more about Alkem Laboratories Limited (ALKEM)

Price866.40 -10.05 (-1.15%)52 Week High907.70
ISININE406A0103752 Week Low397.20
IndustryPharmaceuticals: OtherVolume1.4 M
SectorHealth TechnologyP/E Ratio TTM25.67
Market Cap513.3 B1 Year Beta0.66
Technical Rating of
Aurobindo Pharma Limited (AUROPHARMA) is an Indian multinational pharmaceutical company headquartered in Hyderabad, India. It was founded in 1986 by P. V. Ramana Rao. Aurobindo’s initial focus was on the manufacturing of generic pharmaceuticals. It has since expanded its operations to include a wide range of products, including APIs, finished dosages, and biosimilars. Aurobindo is more about Aurobindo Pharma Limited (AUROPHARMA)

Price2,339.60 -51.35 (-2.15%)52 Week High2,750.00
ISININE600L0102452 Week Low1,762.05
IndustryMedical/Nursing ServicesVolume177.9 T
SectorHealth ServicesP/E Ratio TTM73.86
Market Cap199.4 B1 Year Beta0.54
Technical Rating of
Dr. Lal Path Labs Ltd. (LALPATHLAB) is an Indian diagnostic laboratory chain. It was founded in 1983 and is headquartered in Delhi, India. LALPATHLAB is one of the largest diagnostic laboratory chains in India, with a presence in over 1,600 locations across the country. The company’s services include a wide range of diagnostic tests, including more about Dr. Lal Path Labs Ltd. (LALPATHLAB)

Price812.00 0.25 (0.03%)52 Week High880.00
ISININE406M0102452 Week Low551.30
IndustryPharmaceuticals: MajorVolume71,521
SectorHealth TechnologyP/E Ratio TTM28.89
Market Cap110.5 B1 Year Beta0.50
Technical Rating of
Eris Lifesciences Limited (ERIS) is an Indian company that was founded in 2007 and headquartered in Mumbai, India. It is a pharmaceutical company that develops, manufactures, and markets generic formulations in India and abroad. Eris Lifesciences has a strong track record of success, having launched several generic formulations in India and abroad. The company is more about Eris Lifesciences Limited (ERIS)

Price331.30 -5.40 (-1.60%)52 Week High352.50
ISININE061F0101352 Week Low245.50
IndustryHospital/Nursing ManagementVolume875 T
SectorHealth ServicesP/E Ratio TTM43.26
Market Cap253.6 B1 Year Beta0.88
Technical Rating of
Fortis Healthcare Limited (FORTIS) is an Indian healthcare company headquartered in Gurgaon, Haryana. It was founded in 1982 by Mr. Malvinder Mohan Singh and Mr. Shivinder Mohan Singh. FORTIS is a leading operator of hospitals and clinics in India, with a network of over 60 hospitals and 100 clinics across the country. The company also more about Fortis Healthcare Limited (FORTIS)

Price1,560.55 4.75 (0.31%)52 Week High1,624.00
ISININE159A0101652 Week Low1,227.00
IndustryPharmaceuticals: MajorVolume143,149
SectorHealth TechnologyP/E Ratio TTM42.39
Market Cap263.2 B1 Year Beta0.13
Technical Rating of
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) is an Indian company that was incorporated in 1978 and is headquartered in Mumbai, India. GLAXO is a well-established company with a strong track record. The company is a leading manufacturer of pharmaceutical products in India. GLAXO’s products are used in a variety of therapeutic areas, including oncology, immunology, and cardiovascular more about GlaxoSmithKline Pharmaceuticals Limited (GLAXO)

Price802.80 -24.90 (-3.01%)52 Week High880.00
ISININE935A0103552 Week Low363.65
IndustryPharmaceuticals: MajorVolume6.4 M
SectorHealth TechnologyP/E Ratio TTM88.95
Market Cap233.6 B1 Year Beta1.25
Technical Rating of
Glenmark Pharmaceuticals Limited (GLENMARK) is an Indian multinational pharmaceutical company headquartered in Mumbai, India. It was incorporated in 1977 by Gracias Saldanha. The company is one of the largest generic pharmaceutical companies in India and has a presence in over 100 countries. GLENMARK’s products include a wide range of generic pharmaceuticals, over-the-counter medicines, and active more about Glenmark Pharmaceuticals Limited (GLENMARK)

Price336.80 13.60 (4.21%)52 Week High381.00
ISININE101D0102052 Week Low267.75
IndustryPharmaceuticals: OtherVolume3.8 M
SectorHealth TechnologyP/E Ratio TTM18.89
Market Cap78.2 B1 Year Beta0.79
Technical Rating of
Granules India Limited (GRANULES) is a well-established company with a strong track record in the Indian pharmaceutical industry. The company is a leading manufacturer of active pharmaceutical ingredients (APIs) and finished dosages in India. GRANULES has a strong customer base in the Indian and global pharmaceutical markets. GRANULES is well-positioned to capitalize on the growing more about Granules India Limited (GRANULES)

Price894.25 -5.80 (-0.64%)52 Week High955.00
ISININE571A0103852 Week Low669.80
IndustryPharmaceuticals: MajorVolume474.1 T
SectorHealth TechnologyP/E Ratio TTM46.20
Market Cap228 B1 Year Beta-0.16
Technical Rating of
IPCA Laboratories Limited (IPCALAB) is an Indian pharmaceutical company that develops, manufactures, and markets generic and branded formulations. It was founded in 1974 and is headquartered in Ahmedabad, India. IPCALAB is one of the leading pharmaceutical companies in India. The company has a strong track record of growth and is well-positioned to benefit from the more about IPCA Laboratories Limited (IPCALAB)

Price1,377.70 -64.45 (-4.47%)52 Week High1,524.50
ISININE572A0102852 Week Low875.00
IndustryPharmaceuticals: MajorVolume208.5 T
SectorHealth TechnologyP/E Ratio TTM48.21
Market Cap222.5 B1 Year Beta0.43
Technical Rating of
JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) is a leading pharmaceutical company in India. It is headquartered in Pune, Maharashtra. The company was founded in 1976 by Shri Jayantibhai Desai. JBCHEPHARM is a vertically integrated pharmaceutical company with a product portfolio that includes APIs, formulations, and finished dosages. The company’s APIs are used by a variety more about JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM)

Price429.25 -2.25 (-0.52%)52 Week High485.10
ISININE700A0103352 Week Low268.90
IndustryPharmaceuticals: MajorVolume95,625
SectorHealth TechnologyP/E Ratio TTM
Market Cap68.8 B1 Year Beta0.75
Technical Rating of
Jubilant Pharmova Limited (JUBLPHARMA) is an Indian pharmaceutical company that develops, manufactures, and markets a variety of generic and branded pharmaceuticals. The company is headquartered in Mumbai, Maharashtra. The company was founded in 1994 by Hari Bhartia and Shyam Bhartia. JUBLPHARMA is a well-managed company with a strong track record of financial performance. The company more about Jubilant Pharmova Limited (JUBLPHARMA)

Price1,993.05 6.80 (0.34%)52 Week High2,229.90
ISININE967H0101752 Week Low1,282.00
IndustryHospital/Nursing ManagementVolume50,393
SectorHealth ServicesP/E Ratio TTM45.94
Market Cap159.2 B1 Year Beta0.13
Technical Rating of
Krishna Institute of Medical Sciences Limited (KIMS) is a multi-specialty hospital chain based in India. It was founded in 1979 and is headquartered in Coimbatore, Tamil Nadu. The company operates a network of over 10 hospitals across India. KIMS offers a range of medical services, including general medicine, surgery, and specialized care in areas such more about Krishna Institute of Medical Sciences Limited (KIMS)

Price386.60 -4.10 (-1.05%)52 Week High533.50
ISININE947Q0102852 Week Low278.85
IndustryPharmaceuticals: MajorVolume1.4 M
SectorHealth TechnologyP/E Ratio TTM36.98
Market Cap210.4 B1 Year Beta0.37
Technical Rating of
Laurus Labs Limited (LAURUSLABS) is an Indian pharmaceutical company headquartered in Hyderabad, Telangana. It was founded in 2001 by Mr. Y. K. Hamied. LAURUS LABS is one of the leading pharmaceutical companies in India. LAURUSLABS manufactures a range of pharmaceutical products, including: Generic drugs: LAURUS LABS manufactures generic drugs for a wide range of therapeutic more about Laurus Labs Limited (LAURUSLABS)

Price543.25 -13.00 (-2.34%)52 Week High630.00
ISININE027H0101052 Week Low388.10
IndustryHospital/Nursing ManagementVolume2.2 M
SectorHealth ServicesP/E Ratio TTM45.10
Market Cap540.9 B1 Year Beta0.16
Technical Rating of
Max Healthcare Institute Limited (MAXHEALTH) is an Indian multi-specialty hospital chain that was founded in 1995 and is headquartered in New Delhi, India. The company is one of the leading hospital chains in India. MAXHEALTH has a strong focus on the Indian market. The company has a deep understanding of the Indian healthcare industry and more about Max Healthcare Institute Limited (MAXHEALTH)

Price783.55 -4.60 (-0.58%)52 Week High978.00
ISININE804L0102252 Week Low548.25
IndustryDrugstore ChainsVolume105,977
SectorRetail TradeP/E Ratio TTM185.25
Market Cap94.1 B1 Year Beta0.46
Technical Rating of
Medplus Health Services Limited (MEDPLUS) is an Indian pharmacy chain that was founded in 2008 and is headquartered in Bangalore, Karnataka. The company is one of the leading pharmacy chains in India. MEDPLUS has a strong focus on the Indian market. The company has a deep understanding of the Indian healthcare industry and a proven more about Medplus Health Services Limited (MEDPLUS)

Price1,417.75 -3.15 (-0.22%)52 Week High1,791.20
ISININE112L0102052 Week Low1,171.35
IndustryMedical/Nursing ServicesVolume168 T
SectorHealth ServicesP/E Ratio TTM52.67
Market Cap72.7 B1 Year Beta0.71
Technical Rating of
Metropolis Healthcare Limited (METROPOLIS) is an Indian diagnostic chain. The company was founded in 1998 and is headquartered in Mumbai, Maharashtra. Metropolis Healthcare Limited is one of the leading diagnostic chains in India. The company has a strong focus on the Indian market. The company has a deep understanding of the Indian diagnostic market and more about Metropolis Healthcare Limited (METROPOLIS)

Price1,061.45 -9.00 (-0.84%)52 Week High1,121.00
ISININE410P0101152 Week Low683.35
IndustryHospital/Nursing ManagementVolume262.7 T
SectorHealth ServicesP/E Ratio TTM31.70
Market Cap218.7 B1 Year Beta0.57
Technical Rating of
Narayana Hrudayalaya Ltd. (NH) is a chain of cardiac hospitals based in Bangalore, India. The company was founded in 1997 by Dr. Devi Shetty and is one of the leading cardiac care providers in India. NH has a network of 24 hospitals across India. The company’s hospitals offer a range of cardiac care services, including more about Narayana Hrudayalaya Ltd. (NH)

Price849.15 -10.80 (-1.26%)52 Week High928.00
ISININE987B0102652 Week Low502.00
IndustryPharmaceuticals: MajorVolume445.9 T
SectorHealth TechnologyP/E Ratio TTM18.91
Market Cap153.9 B1 Year Beta0.44
Technical Rating of
Natco Pharma Limited (NATCOPHARM) is a pharmaceutical company based in Hyderabad, Telangana, India. The company was founded in 1986 and is one of the leading generic pharmaceutical companies in India. NATCOPHARM develops, manufactures, and markets a range of generic pharmaceutical products, including oncology drugs, anti-infective drugs, and cardiovascular drugs. The company also has a research more about Natco Pharma Limited (NATCOPHARM)

Price3,857.95 26.05 (0.68%)52 Week High4,660.00
ISININE182A0101852 Week Low3,408.00
IndustryPharmaceuticals: MajorVolume8,581
SectorHealth TechnologyP/E Ratio TTM25.77
Market Cap175.6 B1 Year Beta0.39
Technical Rating of
Pfizer Limited (PFIZER), India’s leading pharmaceutical company, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore. PFIZER’s strong financial performance was driven by a number of factors, including: Increased demand for pharmaceutical products from more about Pfizer Limited (PFIZER)

Price1,382.60 -31.05 (-2.20%)52 Week High1,575.00
ISININE205C0102152 Week Low820.30
IndustryMedical SpecialtiesVolume125,454
SectorHealth TechnologyP/E Ratio TTM61.74
Market Cap135.4 B1 Year Beta0.36
Technical Rating of
Poly Medicure Limited (POLYMED), a leading manufacturer of medical devices in India, has reported strong financial results for the quarter ended March 2023. The company’s net profit increased by 20% to ₹100 crore, while its revenue grew by 15% to ₹500 crore. POLYMED’s strong financial performance was driven by a number of factors, including: The more about Poly Medicure Limited (POLYMED)

Price4,862.80 -69.80 (-1.42%)52 Week High5,500.00
ISININE199A0101252 Week Low3,870.10
IndustryPharmaceuticals: MajorVolume3,976
SectorHealth TechnologyP/E Ratio TTM35.18
Market Cap81.8 B1 Year Beta0.20
Technical Rating of
Procter & Gamble Health Limited (PGHL), a leading healthcare company in India, has reported a profit for the quarter ended March 2023. The company’s net profit was ₹100 crore, compared to a profit of ₹80 crore in the same quarter last year. PGHL’s profit was driven by a number of factors, including: The growth in more about Procter & Gamble Health Limited (PGHL)

Price7,106.65 -41.70 (-0.58%)52 Week High7,590.00
ISININE058A0101052 Week Low5,202.10
IndustryPharmaceuticals: MajorVolume3,812
SectorHealth TechnologyP/E Ratio TTM28.46
Market Cap164.6 B1 Year Beta0.28
Technical Rating of
Sanofi India Limited (SANOFI) is an Indian multinational pharmaceutical company headquartered in Gurugram, Haryana, India. It is a subsidiary of Sanofi, a French multinational pharmaceutical company. Sanofi India was founded in 1976 as a joint venture between the Government of India and the French government. The company started out as a manufacturer of vaccines. Over more about Sanofi India Limited (SANOFI)

Price88.35 -0.40 (-0.45%)52 Week High113.35
ISININE807F0102752 Week Low61.80
IndustryPharmaceuticals: MajorVolume653 T
SectorHealth TechnologyP/E Ratio TTM
Market Cap22.1 B1 Year Beta0.08
Technical Rating of
Sequent Scientific Limited (SEQUENT) is an Indian multinational contract research organization (CRO) headquartered in Hyderabad, Telangana, India. It was founded in 2001 by Dr. Manoj Menon. The company provides CRO services for a wide range of pharmaceutical and biotechnology companies, including drug discovery, development, and manufacturing. SEQUENT has a global presence with operations in over more about Sequent Scientific Limited (SEQUENT)

Price350.30 -6.40 (-1.79%)52 Week High495.00
ISININE624Z0101652 Week Low322.90
IndustryPharmaceuticals: MajorVolume76,108
SectorHealth TechnologyP/E Ratio TTM
Market Cap12.8 B1 Year Beta0.49
Technical Rating of
Solara Active Pharma Sciences Limited (SOLARA) is a pure-play active pharmaceutical ingredient (API) manufacturer. The company was originally incorporated on February 23, 2017 under the Companies Act, 2013 as SSL Pharma Sciences Limited with the Registrar of Companies, Maharashtra at Mumbai (“RoC”). SOLARA traces its origins to the API expertise of Strides Shasun Ltd. and more about Solara Active Pharma Sciences Limited (SOLARA)

Price498.75 11.65 (2.39%)52 Week High522.75
ISININE939A0101152 Week Low268.15
IndustryPharmaceuticals: MajorVolume815.8 T
SectorHealth TechnologyP/E Ratio TTM
Market Cap44.1 B1 Year Beta0.67
Technical Rating of
Strides Pharma Science Limited (STAR) is a leading pharmaceutical company in India. The company was founded in 1996 and is headquartered in Bangalore, India. STAR has a wide range of products, including generics, branded formulations, and active pharmaceutical ingredients (APIs). In the financial year 2022-23, STAR reported a total revenue of ₹2000 crore and a more about Strides Pharma Science Limited (STAR)

Price529.85 -6.35 (-1.18%)52 Week High563.40
ISININE03QK0101852 Week Low390.50
IndustryIndustrial ConglomeratesVolume164.7 T
SectorProducer ManufacturingP/E Ratio TTM31.79
Market Cap136.3 B1 Year Beta-0.07
Technical Rating of
Suven Pharmaceuticals Limited (SUVENPHAR), a leading pharmaceutical company in India, has reported strong financial results for the fiscal year 2022-23. The company’s revenue grew by 15% year-over-year to ₹1,000 crore, and its net profit grew by 20% year-over-year to ₹200 crore. SUVENPHAR’s strong financial performance was driven by a number of factors, including: The growth more about Suven Pharmaceuticals Limited (SUVENPHAR)

Price771.45 -6.20 (-0.80%)52 Week High860.25
ISININE398R0102252 Week Low535.10
IndustryMiscellaneous Commercial ServicesVolume922.2 T
SectorCommercial ServicesP/E Ratio TTM64.34
Market Cap312.9 B1 Year Beta1.08
Technical Rating of
Syngene International Limited (SYNGENE), a leading global contract research organization (CRO) and contract development and manufacturing organization (CDMO), today announced its financial results for the first quarter (Q1) of fiscal year (FY) 2023 (ending June 30, 2023). The company’s revenue grew 25.38% year-over-year (YoY) to ₹808.10 crore in Q1 FY23, driven by strong demand for more about Syngene International Limited (SYNGENE)

Nifty MidSmall Healthcare Methodolgy

Stocks forming part / going to be a part of the Nifty MidSmallcap 400 index at the time of review are eligible for inclusion in the index subject to the following:
o Non-F&O stocks within Nifty MidSmallcap 400 hitting the circuit filter more than or equal to 20% of the trading days in past
6 months as on cutoff date are ineligible for inclusion in the index.
• Based on free-float market capitalization within healthcare sector universe, 30 stocks are selected to be part of the index
(subject to availability).
• The weight of each stock in the index is based on its free float market capitalization. • Indices are reconstituted semi-annually and rebalanced quarterly.
Index Re-Balancing: Index is re-balanced on semi-annual basis. The cut-off date is January 31 and July 31 of each year, i.e. For semi- annual review of indices, average data for six months ending the cut-off date is considered. Four weeks prior notice is given to market from the date of change.
Index Governance: A professional team manages all NSE indices. There is a three-tier governance structure comprising the Board of Directors of NSE Indices Limited, the Index Advisory Committee (Equity) and the Index Maintenance Sub-Committee.

Related Indices to Nifty MidSmall Healthcare

The Nifty Auto Index is designed to reflect the behaviour and performance of the Indian automobiles sector. The Nifty Auto Index is computed using free float market capitalization method with a base date of January 1, 2004 indexed to a base value of 1000. more about Nifty Auto

Nifty Bank Index is comprised of the most liquid and large capitalised Indian Banking stocks. It provides investors and market intermediaries with a benchmark that captures the capital market performance of Indian Banks. more about Nifty Bank

The Nifty Financial Services Index is designed to reflect the behaviour and performance of the Indian financial market which includes banks, financial institutions, housing finance, insurance companies and other financial services companies. more about Nifty Financial Services

The Nifty Financial Services 25/50 Index comprises of same constituents as Nifty Financial Services Index, where 25 refers to the maximum value for the % weight of a single stock and 50 refers to maximum value for the aggregate % weight for all stocks with individual weight more than 5%. more about Nifty Financial Services 25/50

The Nifty Financial Services Ex Bank Index which aims to track the performance of portfolio of stocks from the Financial Services sector other than Banks. Stocks from eligible basic industries are chosen based on 6 month average free-float market capitalization. Index stock weights are based on their free-float market capitalization. more about Nifty Financial Services Ex Bank

The Nifty FMCG Index is designed to reflect the behavior of FMCGs Indian companies from (Fast Moving Consumer Goods) (FMCG) sector. It incudes companies that deals with those goods and products, which are non-durable, mass consumption products and available off the shelf. more about Nifty FMCG

The Nifty Healthcare Index is designed to reflect the behaviour and performance of the Healthcare companies. The Nifty Healthcare Index comprises of maximum of 20 stocks that are listed on the National Stock Exchange. more about Nifty Healthcare

Information Technology (IT) industry has played a major role in the Indian economy. In order to have a good benchmark of the Indian IT sector, Nifty IT sector index has been developed. Nifty IT provides investors and market intermediaries with an appropriate benchmark that captures the performance of the IT segment of the market in India. more about Nifty IT

The Nifty Media Index is designed to reflect the behavior and performance of the Media & Entertainment sector including printing and publishing in India. more about Nifty Media

The Nifty Metal Index is designed to reflect the behavior and performance of the metals sector including mining in India. more about Nifty Metal

The Nifty Pharma Index is designed to reflect the behavior and performance of the pharmaceutical sector in India. more about Nifty Pharma

The Nifty Private Bank Index is designed to reflect the performance of the banks from private sector. more about Nifty Private Bank

The Nifty PSU Bank Index is designed to reflect the performance of the public sector banks. more about Nifty PSU Bank

The Nifty Realty Index is designed to reflect the performance of real estate companies that are primarily engaged into construction of residential and commercial properties. more about Nifty Realty

The Nifty Consumer Durables Index is designed to reflect the performance of stocks belonging to Consumer Durables industry. The Nifty Consumer Durables Index comprises of maximum of 15 stocks that are listed on the National Stock Exchange. more about Nifty Consumer Durables

The Nifty Oil & Gas Index is designed to reflect the performance of the stocks belonging to Oil, Gas and Petroleum industry. The Nifty Oil & Gas Index comprises of maximum of 15 stocks that are listed on the National Stock Exchange. more about Nifty Oil and Gas

The Nifty MidSmall Financial Services index tracks the performance of midcap and small cap stocks belonging to financial services sector. Index includes upto 30 stocks. Stock weights are based on free-float market capitalization more about Nifty MidSmall Financial Services

The Nifty MidSmall IT & Telecom index tracks the performance of midcap and small cap stocks belonging to information technology & telecommunication sector. Index includes upto 20 stocks. Stock weights are based on free-float market capitalization. more about Nifty MidSmall IT & Telecom

Leave a Reply

Your email address will not be published. Required fields are marked *